Principal Financial Group Inc. Sells 21,707 Shares of Synopsys, Inc. $SNPS

Posted by Geri Gentry on Jul 16th, 2026

Principal Financial Group Inc. cut its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 282,987 shares of the semiconductor company’s stock after selling 21,707 shares during the quarter. Principal Financial Group Inc.’s holdings in Synopsys were worth $112,199,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SNPS. Sankala Group LLC purchased a new position in Synopsys during the 4th quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Synopsys in the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Synopsys during the fourth quarter valued at approximately $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys during the fourth quarter valued at approximately $32,000. Finally, Osbon Capital Management LLC purchased a new position in Synopsys during the fourth quarter valued at approximately $34,000. 85.47% of the stock is currently owned by institutional investors.

Synopsys Price Performance

NASDAQ SNPS opened at $425.27 on Thursday. The firm’s fifty day simple moving average is $473.71 and its two-hundred day simple moving average is $459.57. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The firm has a market capitalization of $81.43 billion, a P/E ratio of 98.44, a P/E/G ratio of 2.50 and a beta of 1.22.

Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Insider Transactions at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.

Wall Street Analyst Weigh In

SNPS has been the subject of a number of analyst reports. Morgan Stanley upped their target price on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Rosenblatt Securities lifted their price target on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Benchmark started coverage on Synopsys in a research report on Wednesday. They issued a “buy” rating for the company. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Finally, BNP Paribas Exane lifted their target price on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $570.06.

Check Out Our Latest Report on Synopsys

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.